Theo Outlook
GE HealthCare Technologies Inc. provides medical technology, pharmaceutical diagnostics, and digital solutions in the United States. For the trailing twelve months ending around June 2026, revenue was $21.27 billion, profit margin was 9.33%, earnings per share was $4.50, and market capitalization stood at $32.49 billion.
Bull case: Quarterly revenue grew 5.8% year over year and quarterly earnings grew 16.8% year over year through the latest quarter. Bear case: Profit margin remains at 9.33% and operating margin at 15% for the trailing twelve months.
Main risks include exposure to healthcare sector spending and regulatory changes. The next ex-dividend date is October 23, 2026. Analysis generated by HeyTheo AI from company and market data. It may be incomplete or inaccurate.
Analysis generated by HeyTheo AI on .
